AMTB vs BIIB · P/E 16, rev $268.7M vs P/E 21, rev $9.89B
Amerant Bancorp Inc. (AMTB) versus Biogen Inc (BIIB) — a side-by-side from cached financials, not a winner call.
Amerant Bancorp Inc. (AMTB) is a banks - regional company listed on US.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Latest reported AMTB revenue for 2026-06-30 was $268.7M. Net income was $38.9M. AMTB currently screens at market cap $896.5M and trailing P/E 16.0.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
AMTB currently screens at market cap $896.5M and trailing P/E 16.0. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Not investment advice. Open the AMTB and BIIB stock pages for the full models.
Not investment advice.